Generex adds Emmaus CEO to board
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.
